 "Covaxin, bharat biotech, covid, coronavirus, vaccine, drugs, medicine, pharma")
Bharat Biotech's Covaxin is effective against the Delta and Delta plus variant, a study by the Indian Council of Medical Research and National Institute of Virology has said.
The study released on Monday showed that Covaxin provides 65.2 per cent protection against the Delta variant which was first detected in India. The Delta variant which has spread to 99 countries is a variant of concern and was also responsible for the second wave in India.
The Delta variant has also been identified as the leading cause of breakthrough infections globally among vaccinated individuals, the study said. The study
The study released on Monday showed that Covaxin provides 65.2 per cent protection against the Delta variant which was first detected in India. The Delta variant which has spread to 99 countries is a variant of concern and was also responsible for the second wave in India.
The Delta variant has also been identified as the leading cause of breakthrough infections globally among vaccinated individuals, the study said. The study
